Universe Pharmaceuticals Valuation
| UPC Stock | USD 3.98 0.41 9.34% |
At this time, the company appears to be overvalued. Universe Pharmaceuticals has a current Real Value of $3.67 per share. The regular price of the company is $3.98. Our model measures the value of Universe Pharmaceuticals from inspecting the company fundamentals such as Operating Margin of (0.07) %, shares outstanding of 563.34 K, and Return On Equity of -0.0723 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Universe Pharmaceuticals' valuation include:
Price Book 0.0455 | Enterprise Value | Enterprise Value Ebitda 0.3117 | Price Sales 0.1385 | Enterprise Value Revenue 0.0174 |
Overvalued
Today
Please note that Universe Pharmaceuticals' price fluctuation is very risky at this time. Calculation of the real value of Universe Pharmaceuticals is based on 3 months time horizon. Increasing Universe Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Universe Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Universe Stock. However, Universe Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.98 | Real 3.67 | Hype 4.47 | Naive 4.04 |
The real value of Universe Stock, also known as its intrinsic value, is the underlying worth of Universe Pharmaceuticals Company, which is reflected in its stock price. It is based on Universe Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Universe Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Universe Pharmaceuticals helps investors to forecast how Universe stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Universe Pharmaceuticals more accurately as focusing exclusively on Universe Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Universe Pharmaceuticals' intrinsic value based on its ongoing forecasts of Universe Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Universe Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Universe Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Universe Pharmaceuticals Cash |
|
About Universe Pharmaceuticals Valuation
The stock valuation mechanism determines Universe Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Universe Pharmaceuticals. We calculate exposure to Universe Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Universe Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 5.7 M | 11.1 M | |
| Pretax Profit Margin | (0.24) | (0.22) | |
| Operating Profit Margin | (0.19) | (0.18) | |
| Net Loss | (0.24) | (0.22) | |
| Gross Profit Margin | 0.41 | 0.46 |
Universe Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 3478.00 | |
| Quarterly Earnings Growth Y O Y | -0.82 |
Universe Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Universe Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Universe we look at many different elements of the entity such as Universe's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Universe Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Universe Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Universe Pharmaceuticals' worth.Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |